AB103 Peptide Antagonist in Healthy Volunteers
Clinical trial NCT01166984 · COMPLETED
Trial details
- NCT number
- NCT01166984
- Sponsor
- Atox Bio Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2011-06-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.